Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
Clinical trial NCT01846273 · COMPLETED
Trial details
- NCT number
- NCT01846273
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-07
- Primary completion
- 2016-03-11
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.